Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M223Revenue $M60.4Net Margin (%)-268.5Z-Score-2.1
Enterprise Value $M216EPS $-2.1Operating Margin %-224.7F-Score3
P/E(ttm))0Cash Flow Per Share $-0.8Pre-tax Margin (%)-268.5Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %0Quick Ratio9.3Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %0Current Ratio10.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-51.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-126.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M79.6ROI % (ttm)-40.1Gross Margin Increase y-yN

Gurus Latest Trades with SZYM

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SZYMJohn Burbank 2014-12-31 Reduce-0.13%$2.16 - $7.74
($4.31)
$ 2.80-54%Reduce -17.33%5,872,573
SZYMPRIMECAP Management 2014-12-31 Add0.01%$2.16 - $7.74
($4.39)
$ 2.80-57%Add 22.02%11,892,709
SZYMJohn Burbank 2014-06-30 Add0.18%$9 - $12.22
($10.64)
$ 2.80-280%Add 16.41%6,432,127
SZYMJohn Burbank 2014-03-31 Add1.73%$9.33 - $14.7
($11.74)
$ 2.80-319%Add 2662.64%5,525,277
SZYMPRIMECAP Management 2014-03-31 Add0.02%$9.33 - $14.7
($11.74)
$ 2.80-319%Add 23.54%8,181,189
SZYMPRIMECAP Management 2013-12-31 Add0.05%$8.05 - $11.91
($9.8)
$ 2.80-250%Add 135.49%6,622,113
SZYMJohn Burbank 2013-12-31 Reduce-0.04%$8.05 - $11.91
($9.8)
$ 2.80-250%Reduce -38.66%200,000
SZYMJohn Burbank 2013-09-30 Reduce-0.11%$10.24 - $12.99
($11.39)
$ 2.80-307%Reduce -47.27%326,031
SZYMPRIMECAP Management 2013-09-30 Add0.01%$10.24 - $12.99
($11.39)
$ 2.80-307%Add 42.20%2,812,013
SZYMJohn Burbank 2013-06-30 Reduce-0.11%$7.25 - $12.64
($9.99)
$ 2.80-257%Reduce -35.17%618,261
SZYMPRIMECAP Management 2013-06-30 Buy 0.03%$7.25 - $12.64
($9.99)
$ 2.80-257%New holding1,977,500
SZYMJohn Burbank 2013-03-31 Add0.24%$6.88 - $9.38
($8.27)
$ 2.80-195%Add 443.37%953,613
SZYMJohn Burbank 2012-12-31 Buy 0.05%$6.49 - $11.25
($8.4)
$ 2.80-200%New holding175,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SZYM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SZYM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FIDDLER JERRYDirector 2015-03-10Buy60,000$2.751.82view
Wolfson Jonathan SCEO 2015-03-09Sell33,125$2.694.09view
Painter TylerCFO and COO 2015-03-09Sell19,062$2.694.09view
Licari PeterChief Technology Officer 2015-03-09Sell19,062$2.694.09view
Quinlan Paul TGeneral Counsel 2015-03-09Sell9,687$2.694.09view
FIDDLER JERRYDirector 2015-03-09Buy80,000$2.713.32view
Wolfson Jonathan SCEO 2014-09-22Sell30,000$8.05-65.22view
Painter TylerCFO 2014-09-09Sell44,687$8.52-67.14view
Quinlan Paul TGeneral Counsel 2014-09-09Sell16,562$8.53-67.17view
Wolfson Jonathan SCEO 2014-09-09Sell64,375$8.52-67.14view

Press Releases about SZYM :

    Quarterly/Annual Reports about SZYM:

    News about SZYM:

    Articles On GuruFocus.com
    John Burbank's Top Five Increases of the First Quarter May 29 2013 
    A New Beginning for Codexis? Mar 08 2013 
    comment on SZYM Feb 24 2013 
    comment on SZYM Feb 24 2013 
    comment on SZYM Feb 24 2013 
    comment on SZYM Feb 24 2013 
    comment on SZYM Feb 24 2013 
    Long-term Return Dec 03 2012 
    Weekly CFO Sells Highlight: MMC, LIZ, SZYM, SXCI, PLD Mar 12 2012 
    Strong growth potent Aug 27 2011 

    More From Other Websites
    SOLAZYME INC Financials Mar 14 2015
    10-K for Solazyme, Inc. Mar 08 2015
    SOLAZYME INC Files SEC form 10-K, Annual Report Mar 06 2015
    Solazyme Reports Fourth Quarter and Full Year 2014 Results Mar 03 2015
    PDF Add to Briefcase File is in Briefcase Mar 03 2015
    Solazyme to Participate in the Morgan Stanley MLP/Diversified Natural Gas, Utilities & Clean Tech... Mar 02 2015
    Solazyme to Participate in the Morgan Stanley MLP/Diversified Natural Gas, Utilities & Clean Tech... Mar 02 2015
    Apple, Flowers Foods, Aereo, Solazyme: Intellectual Property Mar 02 2015
    Solazyme reports 4Q loss Feb 26 2015
    Solazyme reports 4Q loss Feb 26 2015
    Solazyme Inc Earnings Call scheduled for 4:30 pm ET today Feb 26 2015
    SOLAZYME INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors... Feb 26 2015
    PDF Add to Briefcase File is in Briefcase Feb 26 2015
    Solazyme Reports Fourth Quarter and Full Year 2014 Results Feb 26 2015
    Q4 2014 Solazyme Inc Earnings Release - After Market Close Feb 26 2015
    SOLAZYME RECEIVES FDA GRAS NO QUESTIONS LETTER FOR HIGH OLEIC ALGAE OIL Feb 24 2015
    Solazyme Receives FDA GRAS No Questions Letter for High Oleic Algae Oil Feb 24 2015
    Solazyme Receives FDA GRAS No Questions Letter for High Oleic Algae Oil Feb 24 2015
    Solazyme to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015 Feb 12 2015
    Solazyme to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015 Feb 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK